CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase Ib/II Study of Anti-PD-1/LAG-3 Bispecific Antibody AK129 Combinations in Advanced Solid Tumors
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06943820
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:44.474953+00:00
- Published At
- 2025-06-03T00:00:00+00:00
- Record Updated At
- 2025-06-03
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Non-small Cell Lung Cancer Stage IIIB/IV", "Head and Neck Squamous Cell Carcinoma (HNSCC)", "Colorectal Adenocarcinoma", "Advanced Solid Tumors"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-06-03"- protocolSection.identificationModule.nctId
"NCT06943820"- protocolSection.identificationModule.officialTitle
"A Phase Ib/II Study of Anti-PD-1/LAG-3 Bispecific Antibody AK129 Combinations in Advanced Solid Tumors"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1", "PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.